Kidney function and drug levels study
Part of Hormones & metabolism clinical trials.
This study looks at how different levels of kidney function affect the amount of a medication in the body. It may help doctors decide on the right dose for people with kidney problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have a certain level of kidney function, from normal to severe kidney failure, but you may or may not be on dialysis.
- You are willing to use effective birth control if you or your partner could become pregnant.
- You have no major changes in your health in the last 30 days and are otherwise in stable condition.
- You can attend all study visits and follow the study rules.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational drug called IGT-303 in people with chronic kidney disease caused by type 2 diabetes. It aims to see if the drug is safe and helpful for slowing kidney damage.
This trial tests a new oral medication (DWP16001) for people with type 2 diabetes who also have moderate kidney problems. It aims to see if the drug is safe and helps control blood sugar while protecting kidney function.
This trial tests whether a new drug, HTD1801, can protect or improve kidney function in people with type 2 diabetes and chronic kidney disease. It may help slow kidney damage and reduce protein in urine.
This study tests a new medicine called AP303 for people with type 2 diabetes and chronic kidney disease. The goal is to see if it is safe and how the body processes it. If you have diabetes and your kidneys are not working as well as they used to, this trial might help find new treatment options.
This study tests a new approach to help your body use insulin better, which may improve blood sugar control and slow down kidney disease. It is for people with advanced chronic kidney disease and type 2 diabetes who are not yet on dialysis.
This study tests an investigational drug called ALN-ANG3 to see if it can help people with diabetic kidney disease. The drug may reduce kidney damage and slow down the loss of kidney function. If you join, you will get the study drug or a placebo (a dummy shot) and be followed by a study doctor.
Hear when a new Type II Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.